Recent developments in the management of idiopathic cholestatic liver disease

about

Recent developments in the management of idiopathic cholestatic liver disease

Item

http://www.wikidata.org/entity/Q42406650

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Recent developments in the management of idiopathic cholestatic liver disease

@en

Recent developments in the management of idiopathic cholestatic liver disease

@nl

type

Item

label

Recent developments in the management of idiopathic cholestatic liver disease

@en

Recent developments in the management of idiopathic cholestatic liver disease

@nl

prefLabel

Recent developments in the management of idiopathic cholestatic liver disease

@en

Recent developments in the management of idiopathic cholestatic liver disease

@nl

P1476

Recent developments in the management of idiopathic cholestatic liver disease

@en

P2093

Emma Weeding

http://www.w3.org/2001/XMLSchema#string

Keith D Lindor

http://www.w3.org/2001/XMLSchema#string

Mohamad H Imam

http://www.w3.org/2001/XMLSchema#string

P2860

Bezafibrate for primary biliary cirrhosis

Bisphosphonates for osteoporosis in primary biliary cirrhosis

Hormone replacement for osteoporosis in women with primary biliary cirrhosis

Methotrexate for primary biliary cirrhosis

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis

A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group

Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis

Primary sclerosing cholangitis.

β-Adrenoceptor blockade in sclerosing cholangitis of Mdr2 knockout mice: antifibrotic effects in a model of nonsinusoidal fibrosis.

P304

317-326

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24714257

http://www.w3.org/2001/XMLSchema#string

P932

3959426

http://www.w3.org/2001/XMLSchema#string